ArticlePain2019

Targeting the CaVα-CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy.

Rajesh Khanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.